Beneath the surface of Cuba’s carefully curated narrative of revolutionary equality lies a reality far more stratified: the chasm between the haves and have-nots has never widened faster. This year, the richest Cubans are not just pulling ahead—they’re rewriting the rules of wealth accumulation in a system where access, connections, and informal economies determine survival more than formal status. The data tells a stark story: while state salaries remain stagnant, a shrinking elite leverages scarcity, state contracts, and black-market arbitrage to inflate fortunes beyond reach.

First, the official statistics remain elusive.

Understanding the Context

Cuba’s National Statistics Office releases sparse, often delayed figures, but independent analysts—drawn from leaked tax records and informal market surveys—estimate the top 1% now controls over 40% of the island’s private wealth. This concentration isn’t accidental. It’s the product of a dual economy where state enterprises, though officially egalitarian, quietly funnel resources to a select clique. These aren’t just government officials; they’re technocrats embedded in foreign joint ventures, state-owned enterprises granted exclusive import rights, and family networks that trace lineage back to pre-revolution elites.

Take the sugar and biotech sectors.

Recommended for you

Key Insights

Sugar, once Cuba’s economic backbone, is now dominated by a handful of private operators who’ve secured special licenses to export refined cane through offshore intermediaries. One source close to Havana’s informal trade corridors revealed that a single licensed exporter—operating under a shell company registered in the Dominican Republic—earns an estimated $12–15 million annually, revenues passed through offshore accounts in the Caymans. This isn’t redistribution; it’s rent extraction cloaked in legal formalities.

Biotech, a rising sector fueled by foreign partnerships, mirrors this trend. State research institutes, starved of funding, now license breakthroughs to multinational pharma firms at undervalued terms. Profits flow upward, concentrated in boardrooms where Cuban executives negotiate with global partners—often without transparency.

Final Thoughts

The result? A class of biotech magnates whose incomes dwarf national averages by a factor of ten, even as 60% of Cubans live on less than $10 a day.

Then there’s real estate—arguably the most visible marker of wealth. In Havana’s historic districts, properties once reserved for state functionaries now trade at premium prices, especially in zones undergoing “rehabilitation” for foreign tourism. A recent investigation uncovered that several luxury renovations funded by Cuban oligarchs use offshore shell entities to mask ownership. A $3 million apartment in Vedado, for instance, was purchased through a Nicaraguan corporation linked to a retired minister—valuing the unit at nearly $4 million in hard currency, a sum accessible only to those with off-the-books capital. The gap between formal income and actual purchasing power has never been wider.

But wealth isn’t just inherited or extracted—it’s cultivated through access.

The so-called “new rich” aren’t just lucky; they’re connected. A network of informal gatekeepers—lawyers with political patronage, logistics brokers embedded in state ports, and financiers with ties to foreign banks—controls entry into high-value sectors. These intermediaries extract rents not through merit, but through influence, turning cronyism into economic policy.

This widening divide isn’t inevitable—it’s systemic. Cuba’s centrally planned economy, designed to suppress inequality, has instead entrenched privilege through opacity and exclusion.